oxazoles has been researched along with Actinomycetoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SH; Gonzalez, E; Molina-Torres, C; Ocampo-Candiani, J; Rendon, A; Velazquez-Moreno, VM; Vera-Cabrera, L; Welsh, O | 1 |
| Cavazos-Rocha, N; Choi, SH; de Torres, NW; Espinoza-González, NA; Lozano-Garza, G; Ocampo-Candiani, J; Said-Fernandez, S; Vera-Cabrera, L; Welsh, O | 1 |
2 other study(ies) available for oxazoles and Actinomycetoma
| Article | Year |
|---|---|
In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycetoma; Mycobacterium tuberculosis; Nocardia; Organophosphates; Oxazoles; Oxazolidinones; Prodrugs; Tetrazoles | 2006 |
Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by Nocardia brasiliensis.
Topics: Acetamides; Actinomycosis; Animals; Disease Models, Animal; Linezolid; Mice; Mice, Inbred BALB C; Mycetoma; Nocardia; Nocardia Infections; Organophosphates; Oxazoles; Oxazolidinones; Prodrugs; Tetrazoles; Treatment Outcome | 2008 |